What dose of Bactrim (trimethoprim‑sulfamethoxazole) should be given to a patient with an estimated glomerular filtration rate of 35 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bactrim Dosing for GFR 35 mL/min

For a patient with GFR 35 mL/min, give half the usual dose of Bactrim (trimethoprim-sulfamethoxazole). This means 1 single-strength tablet (400/80 mg) every 12 hours instead of the standard 1 double-strength tablet (800/160 mg) every 12 hours, or alternatively, 1 double-strength tablet every 24 hours 1.

Dosing Algorithm Based on Renal Function

The FDA label provides clear guidance for dose adjustment based on creatinine clearance 1:

  • GFR >30 mL/min: Use usual standard regimen (no adjustment needed)
  • GFR 15-30 mL/min: Use ½ the usual regimen
  • GFR <15 mL/min: Use not recommended

Your patient with GFR 35 mL/min falls just above the 30 mL/min threshold, technically allowing standard dosing per FDA guidelines. However, recent pharmacokinetic data suggests a more nuanced approach.

Why Consider Dose Reduction at GFR 35?

Recent population pharmacokinetic studies demonstrate that trimethoprim begins accumulating when eGFR drops below 60 mL/min/1.73 m², creating overdose risk, while sulfamethoxazole may actually be underdosed 2. This creates a therapeutic dilemma with the fixed-dose combination.

The safest approach at GFR 35 is to reduce the dose by approximately 16-33% from standard dosing 2. For practical purposes, this translates to:

  • 1 single-strength tablet (400/80 mg) every 12 hours, OR
  • 1 double-strength tablet (800/160 mg) every 24 hours

Clinical Context Matters

The indication affects dosing decisions:

For uncomplicated UTI: Standard duration is 3 days for cystitis 3 or 14 days for pyelonephritis 3. At GFR 35, use reduced dosing as above.

For Pneumocystis pneumonia: Higher doses are required (75-100 mg/kg/day of sulfamethoxazole component) 1, making dose adjustment more complex and requiring therapeutic drug monitoring if available.

Critical Pitfalls

  1. Trimethoprim accumulates more than sulfamethoxazole in renal impairment, increasing risk of hyperkalemia and bone marrow suppression 4

  2. The fixed-dose combination is problematic because the two components have different pharmacokinetics in renal failure—trimethoprim accumulates while sulfamethoxazole may be subtherapeutic 5, 2

  3. Creatinine may rise falsely with Bactrim due to inhibition of tubular creatinine secretion, mimicking worsening renal function without true kidney injury 6

  4. Monitor for adverse effects more closely in renal impairment, particularly thrombocytopenia, hyperkalemia, and rash, as these occur more frequently 7, 4

Monitoring Recommendations

  • Check baseline and follow-up potassium levels (trimethoprim blocks ENaC channels, causing hyperkalemia)
  • Monitor CBC for thrombocytopenia and leukopenia
  • Recheck renal function, but interpret creatinine increases cautiously (may be falsely elevated)
  • Consider cystatin C if available to distinguish true AKI from creatinine secretion inhibition 6

Related Questions

What is the appropriate dosage of Bactrim (trimethoprim‑sulfamethoxazole) for a patient with an estimated glomerular filtration rate of 76 mL/min/1.73 m²?
What is the appropriate renal dosing of Septra (trimethoprim‑sulfamethoxazole) for a patient with a glomerular filtration rate of 21 mL/min?
What renal dose modifications are recommended for trimethoprim‑sulfamethoxazole (cotrimoxazole)?
What is the recommended double‑strength Bactrim (800 mg sulfamethoxazole + 160 mg trimethoprim) dosing for an adult with chronic kidney disease stage 4 (estimated GFR ≈ 15–29 mL/min)?
What is the appropriate renal dosing of trimethoprim‑sulfamethoxazole for a patient with an estimated glomerular filtration rate of 12 mL/min?
Will chewing an iron tablet cause staining of the teeth?
What is the likely cause and recommended management of orthostatic dizziness in a 72-year-old man taking Dovato (dolutegravir + lamivudine) and hydrochlorothiazide 12.5 mg daily?
What are the recommended management strategies for a thumb that intermittently returns to an adducted (closed) position?
Why are angiotensin‑converting enzyme (ACE), aldolase, anti‑ENA antibodies (including anti‑Scl‑70), and antinuclear antibody (ANA) tested in patients with interstitial lung disease?
With a serum vitamin D level of 6.6 ng/mL, should I take 50,000 IU of vitamin D3 twice weekly for repletion?
How should a sudden drop in platelet count from 130 × 10⁹/L to 90 × 10⁹/L, with dengue negative, be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.